![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_6c5a78e8ca55529a3f6c3b506ecb26d6.svg) | Clotrimazole | IC50 | 80.0 [1], 100.0 [2], 690.0 [3] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_6c5a78e8ca55529a3f6c3b506ecb26d6.svg) | Clotrimazole | Ki | 100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_8871e5bc150daca600c47dd7893b11be.svg) | Ethinyl estradiol | IC50 | 3000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_a8643c8f051557f676a3e85676e53d0c.svg) | 1-(2-Chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide | IC50 | 390.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_ec9e5f516f1d61664615a327d768bb8e.svg) | Tiracizine | IC50 | 4078.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_a6df3fd0329794fb2d61c8f2326e7b82.svg) | Androstanol | IC50 | 1200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_74252291d6c1a97e2d369927e3848c37.svg) | Propan-2-yl N-[11-[3-(diethylamino)propanoyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 6400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_5bf53f1028ebaac809540708d1bebef4.svg) | Ethyl 5-(N,N-dimethyl-beta-alanyl)-10,11-dihydro-5H-dibenzo[b,f]azepin-3-ylcarbamate | IC50 | 5010.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_7667ecc0f014e88b55276c2c5875300d.svg) | Ethyl N-[11-[3-(diethylamino)propanoyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 2430.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_da9e3158b51c685ebcac30bf5d8648db.svg) | Carbamic acid, (5-((ethylamino)acetyl)-10,11-dihydro-5H-dibenz(b,f)azepin-3-yl)-, ethyl ester | IC50 | 24490.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_c8777d2ca46006dc3298e730b6987b09.svg) | Carbamic acid, (5-(aminoacetyl)-10,11-dihydro-5H-dibenz(b,f)azepin-3-yl)-, ethyl ester | IC50 | 70000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_dc1383af2fb6f6d06bd9fe0c1ed2e60f.svg) | Cinpa1 | IC50 | 687.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_908382d60550c2043f273676855d2e15.svg) | CID 1069342 | IC50 | 235.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_f24f66aab17cc5997df7e4d37508d190.svg) | Ethyl N-[11-(3-morpholin-4-ylpropanoyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 320.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_034ae6daf262ec90630a901cb8d2c5cf.svg) | Ethyl N-[11-[2-(4-methylpiperazin-1-yl)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 38755.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_b79ae284fca7d494434168379b02fd05.svg) | Ethyl N-[11-[2-(dipropylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 210.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_4f38dc0f8edeeb181c7533ad499fca06.svg) | Propan-2-yl N-[11-(2-piperidin-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 249.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_30469aac76b1053d94d51c2c973b1da5.svg) | Propan-2-yl N-[11-[2-(diethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 680.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_ef3a18beb75df65ad98971e0571ab7d0.svg) | CID 1129891 | IC50 | 620.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_139ec56796c8f319dc79755006cdfc6c.svg) | Propan-2-yl N-[11-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propanoyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 70000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_3d3f5dc4f220df48d320f29d21fbf83a.svg) | Methyl N-[11-(3-morpholin-4-ylpropanoyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 288.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_12df0821c6f74a874b5f4ae2360a0c8f.svg) | Ethyl N-[11-[2-(2,2,6,6-tetramethylpiperidin-1-yl)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 4080.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_bda83eb5e2ec54c2d241b9d7bce399e9.svg) | Ethyl N-[11-[2-(7-azabicyclo[2.2.1]heptan-7-yl)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 1410.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_926917ccfb7a12a73e87d8edafa0ad82.svg) | Ethyl N-[11-[2-(2,5-dioxopyrrol-1-yl)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 39810.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_affdfb1a4b5771cde9ff9713af862e56.svg) | Propan-2-yl N-[11-[2-(2,2-dimethylpropoxy)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 21.2 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_3f040a18ab3304a24092a731893eef2e.svg) | Tert-butyl N-[11-[2-(dipropylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 152.9 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_0cfcfe7def0f33a2af2878c25d52d0b1.svg) | Tert-butyl N-[11-(2-piperidin-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 216.2 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_63a9d202bddda7563dc2c904165e5410.svg) | Tert-butyl N-[11-(2-propan-2-yloxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 116.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_eecd6306aa5f9fa5197740781edaa8db.svg) | Cyclohexyl N-[11-(2-pyrrol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 11.7 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_2b199bb5fdcc932511f672fd5684d5a6.svg) | Propan-2-yl N-[11-(2-cyclopropyloxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 81.5 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_b6ffe510dc0d73243c4e164e537fb9f3.svg) | Propan-2-yl N-[11-(2-cyclobutyloxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 37.6 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_8e8f670d9e0ca704e6126438f925b023.svg) | Propan-2-yl N-[11-(2-cyclopentyloxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 19.5 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_6a2ffe0f44a43b756c87cc86bf2c6921.svg) | Propan-2-yl N-[11-(2-cyclohexyloxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 24.1 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_2f96cfeaf3af025d25f5b60692f790cb.svg) | Tert-butyl N-[11-(2-pyrrol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 31.9 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_2e2c8a36a7fd9c245a43af224673c9a6.svg) | Cyclopropyl N-[11-(2-pyrrol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 22.1 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_9cb3768e477a1b304a2eac8277c7c1ee.svg) | Cyclobutyl N-[11-(2-pyrrol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 20.1 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_fe83e1d9d16c4e362d6527436d8e1691.svg) | Cyclopentyl N-[11-(2-pyrrol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 13.9 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_6a938d7c8fe88b106e9d330e83340a1c.svg) | Ethyl N-[11-(3-pyrrolidin-1-ylpropanoyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 3180.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_9f54ca70fcd7d9c70e1319e48367527a.svg) | Ethyl N-[11-(2-pyrrol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 37.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_cfef764225f66128bd54bec0c428c381.svg) | Ethyl N-[11-[2-(2-methylbutan-2-ylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 2060.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_d95c7b718d03aa9425a897a784484d9f.svg) | Ethyl N-[11-[2-[(2-methylpropan-2-yl)oxy]acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 70.8 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_233a54e4f0fd41bb68c3249b235c0c41.svg) | N-[11-[2-(Diethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]butanamide | IC50 | 2320.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_267e070c6a6ba7425a3b23473b2676bf.svg) | Tert-butyl N-[11-[2-(diethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 1030.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_f3120f2c2649ce38a23faed5b601c9f3.svg) | 1-[11-[2-(Diethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]-3-ethylurea | IC50 | 14420.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_f840d83b8bf6c881dd367d8c1421610d.svg) | 1-[11-[2-(Diethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]-3-propan-2-ylurea | IC50 | 4930.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_bc5f91eef5948e00b3efe8325c43d751.svg) | 1-Tert-butyl-3-[11-[2-(diethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]urea | IC50 | 12970.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_03f21102a3705e1d4b18c02000790cb5.svg) | Ethyl N-[11-(2-imidazol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 6890.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_68fad78004afc63d28c313a6de545b36.svg) | 3-[11-[2-(Diethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]-1,1-diethylurea | IC50 | 13990.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_7e05be451f76400373c6fc2e2ec93d08.svg) | 2-(Diethylamino)-1-[2-(ethylsulfamoylamino)-5,6-dihydrobenzo[b][1]benzazepin-11-yl]ethanone | IC50 | 19090.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_10eb6d9a1500e0aa776f7f71cd4c62b8.svg) | 2-(Diethylamino)-1-[2-[(5-methyl-1,3,4-oxadiazol-2-yl)amino]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]ethanone | IC50 | 18790.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_bc0bbadc6827c4ecc638cb8d39ce47df.svg) | Propan-2-yl N-[11-[2-(dipropylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 116.4 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_6152119df392e433056d893159e3e58e.svg) | Propan-2-yl N-[11-(2-pyrrol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 20.9 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_5ddb5b12092d8c4a75d07d959873835c.svg) | Propan-2-yl N-[11-(2-ethoxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 11350.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_d6961c13e575b589a18aa3d873739def.svg) | Propan-2-yl N-[11-(2-propan-2-yloxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 60.1 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_4ccf92e22aec2a95cd444aa53cc6d006.svg) | Propan-2-yl N-[11-(2-butan-2-yloxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 35.3 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_ecad0cb54f4eb2b456d54f6b80ee69f1.svg) | Ethyl N-[11-[2-[di(propan-2-yl)amino]acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 3050.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_32e000e47f859c77483a3a5866496761.svg) | Ethyl N-[11-(2-pyrrolidin-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 1580.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_e20382e2e7b961b3fa7056d2510f8818.svg) | Ethyl N-[11-[2-(tert-butylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 3631.0 [1] |
![](https://images.aatbio.com/dataset/ic50/nuclear-receptor-subfamily-1-group-i-member-3_2f1673bb55e7ec30be1435c0b8f4aa4c.svg) | Propan-2-yl N-[11-[3-(dimethylamino)propanoyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | IC50 | 1792.0 [1] |